Donor heart preservation: straight up, or on the rocks?

Affiliations

¹ Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton AB T6G 2B7, Canada. Electronic address: dhfreed@ualberta.ca.
² Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton AB T6G 2B7, Canada.

Comment

Darren H Freed et al. Lancet. 2015.

. 2015 Jun 27;385(9987):2552-4.

doi: 10.1016/S0140-6736(15)60614-6. Epub 2015 Apr 14.

¹ Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton AB T6G 2B7, Canada. Electronic address: dhfreed@ualberta.ca.
² Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton AB T6G 2B7, Canada.

No abstract available

Comment on

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J; PROCEED II trial investigators. Ardehali A, et al. Lancet. 2015 Jun 27;385(9987):2577-84. doi: 10.1016/S0140-6736(15)60261-6. Epub 2015 Apr 14. Lancet. 2015. PMID: 25888086 Clinical Trial.